PTEN and neoplasm: Thus short-term treatment with AZD8931 inhibits HER family signalling in both tumour types, and therefore, the differential response of the MMTV-NIC PTEN+/+ and MMTV-NIC PTEN+/− tumours does not reflect an inability of the drug to inhibit the target in the different tumours.